BiotechTube
KoKo

KoKo

London, United Kingdom· Est.
kokopft.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

KoKo operates in the digital health, respiratory, and medical device sectors, providing a full suite of pulmonary function testing solutions. Its core value proposition centers on the KoKo Smart ecosystem, which combines hardware devices known for accuracy and low lifecycle costs with software that enables seamless data review and HL7 integration with hospital EMR systems. The company targets healthcare providers seeking to enhance respiratory diagnostic quality and operational efficiency, leveraging decades of legacy expertise in respiratory technology to serve a global market.

Respiratory

Technology Platform

Integrated hardware and software platform for pulmonary function testing (PFT). Hardware includes FDA-approved PFT machines, spirometers, and respirometers designed for high accuracy and low lifecycle cost. Software platform (KoKo Smart) provides test review, interpretation, and HL7-based EMR interoperability for seamless data integration.

Opportunities

The growing global burden of chronic respiratory diseases (COPD, asthma) and post-COVID lung assessment drives demand for efficient diagnostic tools.
The healthcare industry's shift towards value-based care and operational efficiency creates a strong market for KoKo's low lifecycle cost and EMR-integrated solutions.
There is significant opportunity to displace older, less connected PFT systems in both private practices and large hospital networks.

Risk Factors

Intense competition from large, established medical device companies with greater resources and market presence.
Dependence on regulatory approvals and potential changes in healthcare reimbursement policies for pulmonary function tests.
Execution risks related to scaling operations, maintaining software integration reliability, and adapting to potential technological shifts towards home-based monitoring.

Competitive Landscape

KoKo competes in the pulmonary function testing market against major global players like Vyaire Medical, MGC Diagnostics, and Schiller AG. Its differentiation is based on a combination of claimed hardware accuracy/cost, and particularly its software's promise of rapid, low-cost HL7 EMR integration. It positions itself as a cost-effective and technologically agile alternative to larger, potentially slower-moving incumbents.

More companies in United Kingdom →